chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Opposed to the Booster Formulation of Covid Vaccine (50ug); A rash developed on the bulk of her arm.; Inflammation; Injection site exhibited significant redness; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH (A rash developed on the bulk of her arm.), INFLAMMATION (Inflammation), VACCINATION SITE ERYTHEMA (Injection site exhibited significant redness) and OVERDOSE (Opposed to the Booster Formulation of Covid Vaccine (50ug)) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 100 microgram. On 10-Dec-2021, the patient experienced OVERDOSE (Opposed to the Booster Formulation of Covid Vaccine (50ug)). In December 2021, the patient experienced RASH (A rash developed on the bulk of her arm.), INFLAMMATION (Inflammation) and VACCINATION SITE ERYTHEMA (Injection site exhibited significant redness). On 10-Dec-2021, OVERDOSE (Opposed to the Booster Formulation of Covid Vaccine (50ug)) had resolved. At the time of the report, RASH (A rash developed on the bulk of her arm.) outcome was unknown and INFLAMMATION (Inflammation) and VACCINATION SITE ERYTHEMA (Injection site exhibited significant redness) was resolving.            No Concomitant medications were reported.  No Treatment medications were reported.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Additional Details: Patient complained of tingling in throat & "felt like her tongue was thick". Patient was monitored and was breathing normally with no signs of struggling. A few more minutes passed and patient said she still felt itching and thickness, but still being monitored with no issues or struggling with breathing & she asked about benadryl.dose of benadryl was given & remained to be monitored for an additional 40 min. Patient said she felt fine and it could've been anything that caused itchiness
DEVELOPED ACUTE LEFT SIDED CHEST PAIN ON THE MORNING OF FEBRUARY 28, 2006. THE PATIENT WAS ASLEEP AT THE TIME THE PAIN DEVELOPED.  THE PAIN WAS ASSOCIATED WITH NAUSEA AND DIAPHORESIS BUT NO VOMITING. THE PATIENT WAS TAKEN TO SICK CALL BY THE SICK CALL VAN AND SEEN BY THE PHYSICIAN'S ASSISTANT.  THE PA REFERRED THE PATIENT IMMEDIATELY TO THE EMERGENCY ROOM FOR EVALUATION.  THE PATIENT WAS SEEN ON 2/27/06 FOR TONSILLITIS AND DEHYDRATION.  HE WAS TREATED IN THE THE CLINIC WITH A FEW LITERS OF IV FLUIDS AND IV BICILLIN WITH GOOD RESULTS.  THE PATIENT WAS FOUND TO HAVE AN ABNORMAL EKG WITH WIDESPREAD ST ELEVATION, RIGHT AXIS DEVIATION, CONSIDER PERICARDITIS.  HIS PAIN RESOLVED AFTER ONE SPRAY OF NITROGLYCERIN.  HIS OTHER LABS REVEALED ELEVATED CARDIAC ENZYMES AND TROPONIN. HE WAS ADMITTED TO THE TELEMETRY WARD FOR TREATMENT AND OBSERVATION.  THE PATIENT MADE GOOD PROGRESS AND WAS FOUND SUITABLE FOR DISCHARGE ON MARCH 2, 2006. 05/08/06--8 page medical record received. In addition, a completed VAERS form included as 2 page correspondence. LOS 2/28-3/2-DC DX-acute myopericarditis-with abnormal EKG (non specific ST depression, right axis deviation, widespread ST elevation, elevated cardiac enzymes (positive CPK and troponin and chest pain. HX of asthma. patient will receive permanent exemption status from future smallpox vaccination.
passed out; dizzy; moaning; gasping; foaming in the mouth; headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out) (seriousness criterion medically significant), DIZZINESS (dizzy), MOANING (moaning), DYSPNOEA (gasping), FOAMING AT MOUTH (foaming in the mouth), HEADACHE (headache) and FATIGUE (tired). At the time of the report, LOSS OF CONSCIOUSNESS (passed out), DIZZINESS (dizzy), MOANING (moaning), DYSPNOEA (gasping), FOAMING AT MOUTH (foaming in the mouth), HEADACHE (headache) and FATIGUE (tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Vital signs measurement: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had a severe reaction when he was getting in the car to leave. He was dizzy first then had a blank stare. After that he started moaning and gasping and foaming in the mouth then passed out. They called the paramedics. Vitals were normal and the patient was given the choice to go to the hospital but declined. Patient felt very tired and had a headache later.  No concomitant medications were reported. No corrective treatment was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, medical history and concomitant medication details are required for further evaluation.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up included correct DOB was confirmed; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, medical history and concomitant medication details are required for further evaluation.
Pt had itchy throat after receiving  Moderna Covid 19 Vaccination. Pt was given Benedryl 25mg IM to LT Deltoid ordered by NP.  Pt soon stated his throat no longer felt itchy.
Patient presented to the ED on 4/9/21 and diagnosed with diverticulitis. Patient presented to the ED and was subsequently hospitalized on 4/20/21 with pancreatitis. These visits were within 6 weeks of receiving COVID vaccination.
Fever, body aches, joint pain, exhaustion, breast pain, shortness of breath, migraines, cough, chest tightness, diarrhea  Ventolin Amoxicillin-clav 875-125mg Azithromycin 250mg dose pack Benzonatate 200mg Cefdinir 300mg Levofloxacin 750mg Methylprednisolone 4 mg Prednisone 20mg
This spontaneous report as received from a other refers to an unspecified number of patients of unknown ages and genders. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot# M046005, lot# N01461 and lot# reported as M031971 for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date, the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event was unknown. The reporter considered incorrect product storage and no adverse event to be not related to VARIVAX.     This is one of two reports from the same reporter. ; Sender's Comments:  US-009507513-1708USA012377:
15 year old female who received her first dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine). On 11-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 24-SEP-20155, the patient was vaccinated with an improperly stored dose of ROTATEQ lot # L008053 with expiration date on 30-NOV-2016, oral, (dose was not provided) and RECOMBIVAX HB (dose, route, lot # and expiration date were not provided). The vaccine was exposed to temperature excursion of 34 F during that month. No symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt reports being given Moderna vaccine #2 during clinic on Sunday 4/18/21 by a nursing student.  Shortly after the vaccine she developed severe pain and decreased range of motion of her shoulder, radiating to upper back/neck and chest. She was seen at ED and there was concern the vaccine site was unusually high and possibly injected into a tendon. Pain has persisted over a week, though range of motion is slowly improving.
Muscle soreness and pain upon left shoulder movement upon movement and at rest started evening of 9-30-13, continued pain upon shoulder movement and at rest from 9-30-13 til present; approximately around 10-16-13 additional feelings of numbness, pins/needles, tingling in left arm from shoulder to finger tips til present course of action oral intake of overcounter naproxen and ibuprofen.
Very dizzy; Threw up; Episode of afib; Light headache; A spontaneous report was received from a consumer (patient), 63 years-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 vaccine (mRNA-1273), and experienced, episode of A-fib (atrial fibrillation), very dizzy (dizziness), threw up (vomiting), and light headache (headache).  The patient's medical history included episode of A-fib. Current conditions included diabetic and high blood pressure. No concomitant medications were reported.  On 03 FEB 2021, seven days prior to the onset of events, the patient received their first of planned doses of mRNA-1273 (batch number: 038K20A), intramuscular in the left arm for the prophylaxis of COVID-19 infection.  It was reported that two days ago, the patient had an episode of atrial fibrillation on 10 FEB 2021. The patient doesn't know if it was from the vaccine or something else. The patient usually has 2-3 times of atrial fibrillation a year. She didn't have any other side effects at all right after the vaccine. The patient was a diabetic and didn't call her doctor about this, because it went away. The patient described the atrial fibrillation episode as uncomfortableness and beating of the heart. The patient has an appointment with her cardiologist 2 days before her second shot, and she'd ask him about it. The patient was also wondering that the side effects occurred 8 or 9 days after the shot. She has high blood pressure and took a measurement, and it was normal at 93 (unknown units). The patient had the injection on her left arm because she has a diabetic monitor on right arm. The patient didn't take any treatment for the side effect except one time she took acetaminophen about three days ago when she had a light headache. On 12 FEB 2021, at about 10 am in the morning, the patient got very dizzy and had to sit down on the floor, and she threw up. After that, the patient was feeling fine. The patient gave consent to follow up from safety and to her doctor. No further treatment medications were reported.  Action taken with second dose of mRNA-1273 in response to the events was not reported.   The outcome of the events, episode of A-fib, and light headache were unknown and that of events very dizzy, and vomiting was recovering.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  The patient's medical history of having 2-3 times of atrial fibrillation a year, diabetic and high blood pressure are the risk factors and confounds to the causality.
Extreme itching of arm around injection site began within a minute or tow of the injection. Lasted about 22 minutes. No redness or rash.  Slowly faded away.
I was told to possibly expect an ache at the injection site and flu-like symptoms for a couple of days after the injection. That happened, but the ache in my left arm then generalized to my left side and I got a lot of congestion including bright green mucus for a day. As the congestion cleared after a couple of days, the ache on my left side became very specifically located in my left kneecap, where I fell and bruised myself in August of 2018 (though it had not bothered me since then), As the days went by, the pain became excruciating -- the worst pain I've ever felt, as if an icepick was lodged in my kneecap. No amount of ibuprofen remedied it. As I was about to get on a plane for an extended business trip on May 20, I took myself to the emergency room to ensure that I wasn't experiencing a deep vein thrombosis. They ruled out DVT, said I was safe to fly, prescribed me hydrocodone and lidocaine patches, and advised me to seek medical attention when I returned. For the entire trip, I was in excruciating pain and it eventually became very difficult to walk. I was only able to manage it by taking copious amounts of hydrocodone and naproxen sodium and applying multiple lidocaine patches. Upon arriving back in customs on May 29, I obtained an appointment with Dr, an orthopedist. He prescribed an MRI. The test revealed two torn ligaments on either side of my knee and an "unusual amount of inflammation." In addition to the hydrocodone, doctor prescribed Diclofenac sodium topical gel 1%, which does appear to be helping reduce the inflammation, though the pain is still considerable. The pain is worst at night, requiring me to get up and take more hydrocodone, naproxen, and Diclofenac at about 3am or I have no hope of sleeping further. All in all, this is the most painful medical event I have ever experienced.
injection site soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "He lost his eye sight in service." (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "injection site soreness".   Additional information: Patient had a question that he keeps getting asked by other people and he wants to make sure he informs people correctly. He received both doses. The first injection, he only had injection site soreness, and everything was fine, no other symptoms. On the second jab, he also had injection site soreness and onset of aches and headaches and it was linear started behind the eyes and then down toward the length of his body. 12 hours post injection. Caller states he has a question about ibuprofen or other NSAIDs. Caller stated that 12 hours after symptoms he took 400mg ibuprofen and he didn't consider how it may have blunt or depress the immune response. Attempted to clarify details provided with caller. He clarified he took the ibuprofen 24 hours post injection and 12 hours after onset of symptoms. If it blunted or adversely effected the immune response to the vaccination. He didn't necessarily question the side effects. In regards with self-administration of ibuprofen or any NSAIDS. He supposed in few weeks he could get a titer. He has concerns about the actual level of immunity developed from the second dose and if it may have blunted the effects. It shut down the aches and pains and he's concerned. Reporter details: He is totally blind unless they have talking mail. He lost his eyesight in service.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt  received Havrix and 1st oral Typhoid pill on 06/07/05, 2nd typhoid on 06/09/05 rash started on  06/09/05 3rd typhoid on 06/11/05 4th typhoid on 06/13/2005. Rash is on RL inner and back aspect of thigh. Affected area is 10"x 10". Area has patches that are  red and raised with blister like areas. Size and appearance has not changed since its apppearance Rash is tender, not itchy. Pt applied "ooli cream" This info is from a phone call after 10 days rash is present but only slightly better.
18MAR97 pt called to report confirmed pregnancy of about 10 wk gestation;pt had no indication of pregnancy when seen on 6MAR97;pt had exp menstruation approx 3wk prior to 6MAR97 visit;pt quit oral contraception early MAR97;
Headache, Myalgia & NauseaVomiting Narrative:  Day 1 1/11/21 1420 - I received the vaccine with no reaction throughout the day. Day 2 1/12/21 13:30 - I noticed there was an approximately 2x2 knot where I received the vaccine around. It was slightly red and warm, there was only pain when I touched it. 1600 - I started to have some fatigue. 1800 - I developed body aches (much like the flu) and a headache (but not as intense). My arm is now warm from below the vaccine site to my shoulder.
Infant received Tdap instead of HepB. No adverse events observed. No treatment needed.
I have psoriatic arthritis in different parts of my body specifically hands and feet. After the first vaccine 3 days later the normal pain that I have in my feet which I would say is about a 1 out of 10 Third Day amped up to 10 and lasted 3 to 4 days. After that it dropped down to around 6 or 7 then a few weeks later between 2 and 4. I have never had this type of pain in my feet before so after the first shot I had no other adverse side effects what's the weather from the first shot and 0 from the second shot no side effects
Tingling, hand numbness, venous insufficiency with lower ext swelling. Muscle aches, joint pains. Most improved except leg swelling, VI. Mild joint pain.
Arm swelling, erythema, warmth, tenderness - improved with tylenol.
Starting at the afternoon of receiving the vaccines, patient had nausea and vomiting. Patient could not eat. She had a red, big, warm rash and slight feverthe morning after.
The patient made the appt saying he wanted his first dose of Moderna. He filled out the moderna consent form. He never presented a vaccination card. I asked him prior to giving the shot if this was his first dose of Moderna. He said, yes. I told him he would need a second appt 4 weeks from now which would be February 7th 2022. He said ok. Prior to administering the vaccine I told he he needed to wait for 15 minutes after I gave the shot in case something were to happen. He said ok. I told him I'd write up his vaccine card and hand it to him after 15 min.  He said ok.  About 10 minutes later he comes and asks me if he received the booster dose.  Then shows me his vaccine card.   I am reporting this mainly because he received a 3rd full dose of 0.5ml of Moderna, rather than the 0.25ml booster dose.    His primary series wasn't done according to protocol either. It was NOT administered at our pharmacy. I took the information from Information System.  1st Moderna 0.5ml  1/20/21 2nd Pfizer 0.3ml  2/18/2021  3rd dose (full dose) 01/10/2022  This vaccine history was obtained after the fact.
Patient came in 3 days later with a significant swelling in her left arm about 4 cm but she also had a little bit on rash on the left side of her neck with one possible small blister and she looked red in multiple areas of her skin that didn't have rash.  there were no breathing or throat findings.
Blood pressure also went above normal; heart burn; sleeplessness; hungry; tiredness; could not concentrate; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 44-years-old Non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration, administered in Arm Left on 26Mar2021 18:30 (at the age of 44 years) as single for covid-19 immunization. Medical history included I am Diabetic from an unknown date and unknown if ongoing. There were no concomitant medications. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration, administered in Arm Left on 05Mar2021 18:30 (at the age of 44 years) as single for covid-19 immunization. Patient did not have any known allergies. Patient did not have COVID prior vaccination and was not tested post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications in two weeks. On 28Mar2021 21:00 the patient experienced heart burn and sleeplessness from next 2 days of second dose. Patient started to feel hungry and heartburn and could not sleep for 10 days from there. Patient was also feeling so tiredness and could not concentrate and Blood pressure also went above normal. Adverse Events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood pressure measurement which went above normal on 28Mar2021. Adverse Event was treated by Doctor who suggested to use sleep aid like Benadryl. The outcome of the events was not recovered.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Left deltoid erytematous, warm bandlike streaking 3x4cm diameter with T=99F
At visit had bilateral otitis media persistent but not fever or acute illness and was prescribed Vantin. That evening acute onset of ataxia. Following day, still ataxic but improving otherwise.  Well appearing except for bilateral otitis media. No fever or vomiting. Improving at present.
pain on the bottom of the feet disabled me from walking; Severe joint pain in low extremities; massive swelling of feet; pain on the bottom of the feet disabled me from walking; This is a spontaneous report from a contactable consumer. A 38-year-old female consumer (patient) reported for herself that she received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EW0186) via an unspecified route of administration in left arm on 08Jun2021 11:00AM at single dose for COVID-19 immunisation. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EW0185) via an unspecified route of administration in left arm on 18May2021 12:00PM for COVID-19 immunisation. Relevant medical history included hyperactive thyroid. Concomitant medications were not reported. On 30Jun2021 16:00 the patient had severe joint pain in low extremities, massive swelling of feet, pain on the bottom of the feet disabling her from walking, could not go down/up the stairs. The events resulted in doctor or healthcare professional office/clinic visit. The patient received prescriptions with a lot of tests and X-rays. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, it is unknown whether the patient has been tested for COVID-19. The events were resolving at the time of report.